Zaburzenia procesu O-GlcNAcylacji w nowotworach

Journal Title: Folia Medica Lodziensia - Year 2014, Vol 41, Issue 1

Abstract

O-GlcNAcylation is a post-translational modification involving the addition of a N-acetylglucosamine moiety to the serine/threonine residues of cytosolic or nuclear proteins. Two enzymes are responsible for cyclic O-GlcNAcylation: O-GlcNAc transferase (OGT) which catalyzes the addition of the GlcNAc moiety from UDP-GlcNAc to target proteins and O-GlcNAcase (OGA) which catalyses the hydrolytic removal of the sugar moiety from proteins. Dynamic and reversible O-GlcNAcylation is emerging as an important regulator of diverse cellular processes, such as signal transduction, metabolism, transcription, translation, proteasomal degradation and cell cycle. O-GlcNAcylation occurs on serine or threonine residues of proteins at sites that may also be phosphorylated. Therefore, an extensive crosstalk exists between phosphorylation and O GlcNAcylation. Recent studies indicate that increased O-GlcNAcylation is a general feature of cancer. Elevated O-GlcNAcylation (hyper-O-GlcNAcylation) occurs in many human malignancies including solid tumors such as lung, prostate, breast, colorectal, liver, pancreatic cancers as well as non solid cancers such as chronic lymphocytic leukemia. The changes in O GlcNAcylation are associated with the changes in OGT and OGA expression levels. Hyper-O-GlcNAcylation may be linked to the various hallmarks of cancer, including cancer cell proliferation, survival, invasion, metastasis and metabolism. This paper reviews recent findings related to O GlcNAc-dependent regulation of signaling pathways, cell cycle, transcription factors, and metabolic enzymes in cancer cells.

Authors and Affiliations

Piotr Ciesielski, Anna Krześlak

Keywords

Related Articles

Analysis of polymorphisms / mutations of PTEN, CDKN2A, TP53 genes and of hMSH6 gene in endometrial hyperplasia and carcinoma

Endometrial cancer belongs to the most frequent malignancies in the female genital organs with a growing incidence trend. The molecular changes, which are specific for particular stages of neoplastic transformation or th...

Rola mesalazyny w chemoprewencji raka jelita grubego

Colorectal cancer (CRC) is the fourth most commonly diagnosed cancer in females and the third in males. Every year there are more than a million new cases of colorectal cancer and more than six hundred thousand patients...

Wydzielanie serotoniny i melatoniny oraz mioelektryczna i motoryczna czynność żołądka u kobiet po menopauzie

In postmenopausal women various psychosomatic disorders concerning mood and appetite occur. The reason is not only estrogen deficiency, but also other hormones and neurotransmitters. The aim of the study was to estimate...

Rola tryptofanu i serotoniny w patogenezie i leczeniu zespołu jelita nadwrażliwego

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder of a very complex etiopathogenesis. There are three clinical types of this syndrome: with constipation, with diarrhea and mixed, with alternating c...

Ocena profilu lipidowego u pacjentów aglomeracji łódzkiej leczonych statynami

Introduction: In more than the half of the population in Europe, including Poland, blood lipid profile is abnormal. These abnormalities are: high total cholesterol (TCh) levels (> 5.0 mmol/L or 190 mg/dL), often accompan...

Download PDF file
  • EP ID EP169353
  • DOI -
  • Views 82
  • Downloads 0

How To Cite

Piotr Ciesielski, Anna Krześlak (2014). Zaburzenia procesu O-GlcNAcylacji w nowotworach. Folia Medica Lodziensia, 41(1), -. https://europub.co.uk/articles/-A-169353